Guayusa extract shows dose-dependent nootropic effects in study

A study done on a proprietary guayusa leaf extract found dose-dependent effects. A low dose did better at boosting cognitive performance and mood, while the high dose boosted reaction times in a psychomotor hop test.

Hank Schultz, Senior Editor

July 23, 2024

3 Min Read

At a Glance

  • A new study delved into dose-dependent effects of a guayusa extract. 
  • The extract has both caffeine and chlorogenic acid, which could provide an entourage effect. 
  • The study found better cognitive outcomes for a low dose, more psychomotor benefits with a high dose. 

A proprietary guayusa extract showed both cognitive/mood as well as psychomotor benefits in a dose-dependent manner in a recent study funded by the brand holder. 

The new research was published in the Journal of the International Society of Sports Nutrition. It was the work of a research team from the University of Iowa Department of Health and Human Physiology. 

The research was funded by Applied Food Sciences (AFS) of Kerrville, Texas. The study was done with the company’s proprietary guayusa extract, which is branded as AmaTea. The authors said they had full responsibility for the content and conclusions of the study. 

Long history of use 

Guayusa (Ilex guayusa) is an evergreen, broadleaf tree in the holly family. It is native to the western portions of the Amazonian rainforest. The plant, which has a long history of traditional use in the form of teas brewed with the leaves, has been cultivated for centuries. AFS says it works with a network of farmers in the region to source its organic raw material. 

The leaves contain caffeine, and extracts of the leaves are often used in products to offer a natural caffeine source. However, the leaves also contain chlorogenic acids.  

The study’s authors noted that past research opens the door for an entourage effect between the two substances, especially when a nootropic effect (as opposed to a mere stimulant effect) is desired. In this context, a nootropic could be defined as a product that boosts cognitive function, cognitive flexibility, concentration and attention. 

Two aspects of extract working together 

Caffeine works primarily by acting as an adenosine receptor antagonist, which indirectly alters the release of neurotransmitters that include dopamine, serotonin, and norepinephrine. This works to heighten arousal, making caffeine users feel more focused and energetic. 

The authors noted that caffeine shows a mood-heightening quality at low to moderate doses, while at higher doses it can increase feelings of anxiety and jitteriness. Meanwhile, recent research has shown that chlorogenic acid may boost mood all on its own. 

Because of the dose-dependent nature of caffeine’s effects, the researchers designed a study to delineate the effects of the branded extracts at both a low (600 milligrams) (mg) and high (1200 mg) dose. 

The researchers used a blinded, placebo-controlled crossover design with a cohort of 25 younger, healthy and physically active subjects. All the subjects consumed a low and high dose of the guayusa extract and an equivalent placebo. 

For each of the three experimental rounds, the subjects arrived at the testing facility where, after a period of rest, their baseline blood pressure and pulse were recorded. Then, they took one of the three interventions followed by rest. 

Immediately thereafter, they performed a battery of cognitive tests and filled out mood questionnaires. They also performed four validated hop tests to examine the psychomotor effects of the two extracts. 

Dose depends on desired effects 

The results showed some surprising effects that were in fact dose dependent. The low-dose guayusa leaf extract (GLE) improved mood and cognitive performance, while the high-dose GLE was more effective at improving psychomotor speed in the hop test. Both extracts increased blood pressure, but not heart rate. The high dose did tend to increase jitteriness, but only among the female subjects, the researchers said. 

“Our findings have important implications for GLE dosing, which should be dependent on the goal of supplementation and the target population,” they concluded. 

 

 

About the Author

Hank Schultz

Senior Editor, Informa

Hank Schultz has been the senior editor of SupplySide Supplement Journal (formerly Natural Products Insider) since early 2023. He can be reached at [email protected]

Prior to joining the Informa team, he was an editor at NutraIngredients-USA, a William Reed Business Media publication.

His approach to industry journalism was formed via a long career in the daily newspaper field. After graduating from the University of Wisconsin with degrees in journalism and German, Hank was an editor at the Tempe Daily News in Arizona. He followed that with a long stint working at the Rocky Mountain News, a now defunct daily newspaper in Denver, where he rose to be one of the city editors. The newspaper won two Pulitzer Prizes during his time there.

The changing landscape of the newspaper industry led him to explore other career paths. He began his career in the natural products industry more than a decade ago at New Hope Natural Media, which was then part of Penton and now is an Informa brand. Hank formed friendships and partnerships within the industry that still inform his work to this day, which helps him to bring an insider’s perspective, tempered with an objective journalist’s sensibility, to his in-depth reporting.

Harkening back to his newspaper days, Hank considers the readers to be the primary stakeholders whose needs must be met. Report the news quickly, comprehensively and above all, fairly, and readership and sponsorships will follow.

In 2015, Hank was recognized by the American Herbal Products Association with a Special Award for Journalistic Excellence.

When he’s not reporting on the supplement industry, Hank enjoys many outside pursuits. Those include long distance bicycle touring, mountain climbing, sailing, kayaking and fishing. Less strenuous pastimes include travel, reading (novels and nonfiction), studying German, noodling on a harmonica, sketching and a daily dose of word puzzles in The New York Times.

Last but far from least, Hank is a lifelong fan and part owner of the Green Bay Packers.

Subscribe for the latest consumer trends, trade news, nutrition science and regulatory updates in the supplement industry!
Join 37,000+ members. Yes, it's completely free.

You May Also Like